Casi PharmaceuticalsCASIF
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 24 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, up 1 from Q1 2025. 3 opened new positions and 2 sold out. The largest holders were Venrock Adviser, LLC ($1.2M), Foresite Capital Management VI LLC ($929K) and Woodline Partners LP ($195K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $56K |
| Exits | 2 | $272 |
All 13F filers, Q1 2025 → Q2 2025: 61,684 shares bought and 560,632 shares sold, net −498,948 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Venrock Adviser, LLC | 0.09% | No change | 987,259 | $1.2M |
| Foresite Capital Management VI LLC | 0.52% | Reduce -40.8% | 787,121 | $929K |
| Woodline Partners LP | 0.00% | Add +0.8% | 165,640 | $195K |
| Wellington Shields Capital Management, LLC | 0.02% | Reduce -0.1% | 90,845 | $107K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -7.0% | 44,120 | $52K |
| Renaissance Technologies | 0.00% | Add +0.8% | 39,200 | $46K |
| Citadel Advisors | 0.00% | New | 36,246 | $43K |
| Wellington Shields & Co., LLC | 0.01% | No change | 30,091 | $36K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.9% | 18,808 | $22K |
| Bank of America Corp. | 0.00% | Add +18174.2% | 12,061 | $14K |
| Two Sigma Securities, LLC | 0.00% | New | 11,599 | $14K |
| Susquehanna International Group, LLP | 0.00% | Reduce -52.0% | 10,151 | $12K |
| Royal Bank of Canada | 0.00% | Add +2.6% | 9,950 | $11K |
| UBS Group AG | 0.00% | Reduce -69.1% | 954 | $1K |
| Wells Fargo & Company | 0.00% | No change | 505 | $596 |
| Morgan Stanley | 0.00% | Reduce -75.5% | 365 | $431 |
| BlackRock, Inc. | 0.00% | No change | 296 | $349 |
| BNP Paribas Financial Markets | 0.00% | No change | 134 | $158 |
| JPMorgan Chase & Co. | 0.00% | No change | 25 | $30 |
| Citigroup Inc. | 0.00% | New | 19 | $22 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 13 | $15 |
| Colonial Trust Co / SC | 0.00% | No change | 11 | $13 |
| MAI Capital Management | 0.00% | No change | 5 | $6 |
| Simplex Trading, LLC | 0.00% | Reduce -77.2% | 26 | $0 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.